These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2540356)

  • 21. Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.
    Van 't Wout JW; Meynaar I; Linde I; Poell R; Mattie H; Van Furth R
    J Antimicrob Chemother; 1990 May; 25(5):803-11. PubMed ID: 2165051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antifungal activities of D0870 against fluconazole-resistant Candida albicans].
    Kojima M; Yamada H; Nakamura S; Kikuchi M; Nakanishii T; Takahashi Y; Mochizuki H; Mikami Y
    Nihon Ishinkin Gakkai Zasshi; 1999; 40(4):209-15. PubMed ID: 10536307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2862-4. PubMed ID: 11557481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy.
    McIntyre KA; Galgiani JN
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1095-100. PubMed ID: 2551215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fungistatic effects of optical brightener 220 against Trichophyton tonsurans, Aspergillus fumigatus and Candida albicans.
    Sadeghi G; Khaksar AA; Bassiri Jahromi S; Amirkhani A; Eslamifar A; Ajdary S; Katiraee F; Taeb J; Paskiabi FA; Sayyah M
    J Dermatolog Treat; 2009; 20(2):120-3. PubMed ID: 19003591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens.
    Yenişehirli G; Bulut Y; Güven M; Günday E
    J Laryngol Otol; 2009 Sep; 123(9):978-81. PubMed ID: 19454132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro evaluation of the sensitivity to fluconazole of different species of yeasts isolated in pathology].
    Regli P; Blancard A; Goudard M; Moulin-Traffort J; Sarzier JM; Quilici M
    Pathol Biol (Paris); 1992 May; 40(5):500-6. PubMed ID: 1495834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans.
    Hughes CE; Bennett RL; Tuna IC; Beggs WH
    Antimicrob Agents Chemother; 1988 Feb; 32(2):209-12. PubMed ID: 2834995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal action of Hevea brasiliensis latex. Its effect in combination with fluconazole on Candida albicans growth.
    Giordani R; Gachon C; Buc J; Regli P; Jacob JL
    Mycoses; 1999; 42(7-8):465-74. PubMed ID: 10546488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
    Carrillo-Muñoz AJ; Quindós G; Gasser I; Tur-Tur C; Ruesga MT; Alonso-Vargas R; Arévalo P; Bornay-Llinares FJ; Santos P; del Valle O
    Rev Esp Quimioter; 1999 Jun; 12(2):126-35. PubMed ID: 10562673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro studies of a new antifungal triazole, D0870, against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts.
    Peng T; Galgiani JN
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2126-31. PubMed ID: 8257134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
    Yücesoy M; Marol S
    Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans.
    Hirasawa M; Takada K
    J Antimicrob Chemother; 2004 Feb; 53(2):225-9. PubMed ID: 14688042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
    Wildfeuer A; Seidl HP; Paule I; Haberreiter A
    Arzneimittelforschung; 1997 Nov; 47(11):1257-63. PubMed ID: 9428984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
    Liu P; Zhu S; Li P; Xie W; Jin Y; Sun Q; Wu Q; Sun P; Zhang Y; Yang X; Jiang Y; Zhang D
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3261-5. PubMed ID: 18467095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of fluconazole on Candida albicans.
    Abecia LC; Arévalo JM; López MJ
    Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.